Mid-Q Response Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 177 participants.
Also called NCT04180696
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 177 participants
- Registry
-
NCT04180696
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Brunei, China, Hong Kong SAR China, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT04180696. Randomized; single masking; primary purpose treatment. Start 2020-01-23 (actual); primary completion 2024-03-28 (actual). Results posted on 2025-05-30.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Mid-Q Response Study
- Condition
- Heart Failure
- Condition
- Left Bundle-Branch Block
- Condition
- Heart Failure NYHA Class II
- Condition
- Heart Failure NYHA Class III
- Condition
- Heart Failure NYHA Class IV
- Intervention (Device)
- aCRT ON
- Intervention (Device)
- aCRT OFF
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Collaborator
- Medtronic
- Collaborator
- Medtronic Japan Co., Ltd.
Record details
- Record id
cardio:ct-nct04180696- Content hash
a67daa481496990fc4da3026fa2977d525391abc296e8b02901e8c7e504fd976